ComboMATCH: Precision Medicine Trials ComboMATCH is a large precision medicine initiative with a coordinated set of clinical trials evaluating new anti-cancer drug combinations in select groups of adults and children with cancer. Click here to learn more.
myeloMATCH: Precision Medicine Trials MyeloMATCH (Myeloid Malignancies Molecular Analysis for Therapy Choice) is a group of precision medicine clinical trials consisting of an initial screening study and multiple treatment trials for people with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML). Click here to learn more.
